Elena Vigliar

3.1k citations
105 papers · 1.8k indexed · h-index 27

Elena Vigliar

98 papers receiving 1.8k citations

Peers

Elena Vigliar
Comparison fields: 5 of 94
  • Cancer Research 594
  • Oncology 762
  • Pathology and Forensic Medicine 401
  • Pulmonary and Respiratory Medicine 693
  • Otorhinolaryngology 68
Replace Claudio Bellevicine with:
Claudio Bellevicine Italy
Pasquale Pisapia Italy
Min‐Shu Hsieh Taiwan
Sandra Lassalle France
Immacolata Cozzolino Italy
Laura J. Tafe United States
Kuan‐Ting Kuo Taiwan
Hyun Ae Jung South Korea
Nancy P. Caraway United States
Élodie Long-Mira France
Elena Vigliar relative to Claudio Bellevicine Italy Claudio Bellevicine's profile →
Citations per field
00.5×3.4×
Claudio Bellevicine · 1×
Citations per year

Countries citing papers authored by Elena Vigliar

Since Specialization
Citations

This map shows the geographic impact of Elena Vigliar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Vigliar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Vigliar more than expected).

Fields of papers citing papers by Elena Vigliar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Vigliar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Vigliar. The network helps show where Elena Vigliar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elena Vigliar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elena Vigliar Line = papers co-authored together Elena Vigliar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20250
4 20242
5 20243
6 20242
7 20232
8 20222
9 20228
10 20225
11 20226
12 202135
13 202111
14 202128
15 20212
16 201915
17 201831
18 201729
19 201466
20 20138

About Elena Vigliar

Elena Vigliar is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 105 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Cancer Genomics and Diagnostics (31 papers), Thyroid Cancer Diagnosis and Treatment (18 papers), Lymphoma Diagnosis and Treatment (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Genetic factors in colorectal cancer (10 papers), Salivary Gland Tumors Diagnosis and Treatment (9 papers) and Lymphadenopathy Diagnosis and Analysis (8 papers). The work is most often cited by research in Cancer Research (594 citations), Oncology (762 citations) and Pathology and Forensic Medicine (401 citations). Elena Vigliar has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Giancarlo Troncone, Claudio Bellevicine, Umberto Malapelle, Pasquale Pisapia, Caterina De Luca, Roberta Sgariglia, Pio Zeppa, Antonino Iaccarino, Francesco Pepe and Marco Picardi. Their work appears in journals such as SHILAP Revista de lepidopterología, European Journal of Cancer and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026